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Abstract
Lower bone mineral density (BMD) in smokers may be attributable to lower body weight or fat mass, rather than to a direct
effect of smoking. We analyzed the effects of smoking exposure, assessed by plasma cotinine, and body fat on BMD and the
risk of subsequent hip fracture. In the community-based Hordaland Health Study (HUSK), 3003 participants 46–49 years and
2091 subjects 71–74 years were included. Cotinine was measured in plasma and information on health behaviors was
obtained from self-administered questionnaires. BMD and total body soft tissue composition were measured by dual X-ray
absorptiometry. Information on hip fracture was obtained from computerized records containing discharge diagnoses for
hospitalizations between baseline examinations 1997–2000 through December 31st, 2009. In the whole cohort, moderate
and heavy smokers had stronger positive associations between fat mass and BMD compared to never smokers (differences
in regression coefficient (95% CI) per % change in fat mass = 1.38 (0.24, 2.52) and 1.29 (0.17, 2.4), respectively). In moderate
and heavy smokers there was a nonlinear association between BMD and fat mass with a stronger positive association at low
compared to high levels of fat mass (Davies segmented test, p,0.001). In elderly women and men, heavy smokers had an
increased risk of hip fracture compared to never smokers (hazard ratio = 3.31, 95% CI: 2.05, 5.35; p,0.001). In heavy smokers
there was a tendency of a lower risk of hip fracture with higher percentage of fat mass. The deleterious effect of smoking on
bone health is stronger in lean smokers than in smokers with high fat mass.
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Introduction
Cigarette smoking is associated with low bone mineral density
(BMD) [1,2] and increased risk of fracture [1–4] in both women
and men. The mechanisms behind the negative effects of smoking
on bone are not completely known, but it is partly related to the
influence from smoking on sex hormones in both genders [5]. A
direct adverse effect of smoking on skeletal remodeling and bone
cells has also been suggested [6], and in an animal model impaired
bone formation was seen during nicotine exposure [7]. Further,
smoking may decrease calcium absorption [8] and parathyroid
hormone concentration [9].
Low body weight and low body mass index (BMI) are associated
with low BMD [10], but the association between low BMI and
fracture risk seems to be site specific. In some previous studies low
BMI was associated with hip [11–13] and lower extremities
fractures [12], while in a meta-analysis low BMI was associated
with increased risk of all types of fractures [14]. In recently
published studies the results are conflicting [15,16]. Low fat mass
has been associated with increased risk of vertebral fractures in
men [17] and hip fractures in women [11]. Accordingly, fat mass
has been found to be positively associated with BMD in both
women and men in some [18–20], but not all [21,22] studies. In a
recently published meta-analysis including 44 studies, only four
reported negative associations between fat mass and BMD in any
participant subgroups [23]. Biochemical interactions between
adipose tissue and bone are complex and linked by a multitude of
pathways involving cytokines, adiponectin, insulin, and leptin, and
hormones like insulin and estrogen [24].
On average, smokers have lower weight and lower fat mass than
non-smokers [25]. In a Danish study on perimenopausal women a
significant interaction was found between low fat mass (,13.3 kg)
and current smoking on femoral neck BMD, demonstrating that
among women with high fat mass (.19.0 kg) smoking did not
affect BMD [25]. A Norwegian study described a 3-fold increased
risk of hip fracture in lean (BMI#20 kg/m2) female smokers
compared to lean non-smokers, but no increased risk in smokers
with BMI above the population mean (.25 kg/m2) [3]. In men a
2-fold increased risk of hip fracture was found in smokers
compared to non-smokers independently of BMI [3].
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Studies of the association between smoking, BMD and fracture
risk have mostly been based on self-reported smoking [1,2] with its
inherent limitations. Cotinine is the main metabolite of nicotine
and a sensitive marker of recent active and passive tobacco
exposure. While nicotine has a half-life of only 2–3 hours, cotinine
has a half-life of 11–37 hours [26].
To our knowledge, plasma cotinine-based classification of
smoking habits has not been studied as a predictor of risk of hip
fractures, and the effect of smoking exposure and fat mass on
BMD and hip fracture risk has not been reported. We
hypothesized that there is a higher risk of low BMD and hip
fracture in lean smokers than in smokers with high fat mass. We
also wanted to investigate the interaction between fat mass and
smoking in relation to BMD and hip fracture.
The independent impact of fat mass and lean mass on BMD has
been previously studied in this population [20]. The aim of the
present study was to explore whether the deleterious effect of
smoking on BMD and hip fracture risk was the same regardless of
body composition/the proportion of fat mass.
Methods
Ethics statements
The study was approved by the Regional Committee for
Medical Research Ethics review, REC West. Each participant
signed an informed consent form.
Study population
Men and women, residing in Bergen (Norway) and three
neighboring municipalities, born 1925–1927 and 1950–1951 were
invited for the main Hordaland Health Study (HUSK) where the
baseline examination was done during 1998–2000. Those invited
had participated in a previous study (The Hordaland Homocys-
teine Study) during 1992–93 [27]. Altogether 77% met for the
main study and they received an invitation for densitometry
measurements. A total of 5408 (73.8%) met for this substudy.
Inclusion criteria for the present study were participants with valid
total body and femoral BMD scans and plasma cotinine
measurements. Thirty subjects were excluded because of invalid
BMD scans or bilateral hip prostheses. Total body soft tissue
composition was invalid in 183 subjects (motion or metal artifacts).
Thirty-nine persons were excluded because of non-white ethnicity.
Lastly, plasma cotinine measurements were missing in 62 subjects.
Thus, 5094 participants (1821 women and 1182 men aged 46–49
years and 1126 women and 965 men aged 71–74 years) comprise
the cohort of the current study. Follow-up time was from inclusion
until first hip fracture, while the observations were censored at
death or on December 31st, 2009. As only eight participants in the
youngest age group were diagnosed with a hip fracture during the
follow-up period, only the oldest age group was included in the hip
fracture analyses. During the follow-up period, 218 women and
309 men died without having suffered a hip fracture.
Bone mineral density and body composition
BMD and total body soft tissue composition was measured by
dual X-ray absorptiometry (DXA) on a stationary fan beam
densitometry (Expert-XL; Lunar Company Inc, Madison, Wis) by
four trained technicians. The left hip was scanned except when
there was a history of hip prosthesis or fracture. The results were
based on measurements of femoral neck BMD as this measure-
ment site is recommended as the reference standard for
description of osteoporosis [28]. Fat mass (%) was calculated as
fat mass (kg) in percent of total body weight (kg). Daily scanning of
the manufacturer-supplied spine phantom showed no instrumen-
tation drift and a coefficient of variation of ,0.9% during the
whole study period.
Hip fractures
Information on hip fracture was attained from computerized
records containing discharge diagnoses for all hospitalizations
occurring between HUSK baseline examinations through Decem-
ber 31st, 2009 at the six hospitals in Hordaland County. Mean
follow-up time was 9.8 years. Hip fracture was defined as the first
fracture of the proximal femur occurring during the observation
period. Only hip fractures confirmed by a concurrent code of an
adequate surgical procedure were included in order to validate the
fracture registration; all hospital discharges with an identified hip
fracture diagnosis were searched for adequate surgical treatment.
Further description of the classification codes is previously
described [29]. Information on time of death was attained from
the Norwegian Population Register.
Other measurements
Height and weight were measured with light clothing. BMI was
calculated as weight in kilograms divided by the square of height in
meters. Self-administered questionnaires provided information on
smoking, physical activity and hormone replacement therapy,
which were missing in 13, 160 and 743 participants, respectively.
Smoking habits were categorized as current, former or never-
smokers. The number of cigarettes smoked daily was also
collected. Leisure time physical activity was categorized as no or
light regular activity (,1 hour/week), regular (1–2 hours/week)
and hard regular activity ($3 hours/week). Use of estrogen
supplements was categorized as current or no use. Information on
dietary intake was collected using a validated 169-item food
frequency questionnaire (FFQ). FFQ was missing in 482 subject,
and eight participants with energy intake extremes (,2.5 or.97.5
percentiles) were excluded.
Determination of cotinine and categorization of smoking
Non-fasting blood samples were collected and plasma was
stored at 280 degrees Celsius. Plasma cotinine concentration was
measured by liquid chromatography-tandem mass spectrometry at
the laboratory Bevital A/S (Bergen, Norway) [30]. Never smoking
was defined as plasma cotinine levels less than 85 nmol/L [31]
and no report of previous smoking. Former smoking was defined
as self-reported previous smoking and plasma cotinine levels less
than 85 nmol/L. Moderate smoking was defined as plasma
cotinine levels between 85 and 1199 nmol/L and heavy smoking
as 1200 nmol/L or higher. A plasma cotinine level of 1200 nmol/
L corresponded to a self-reported consumption of about 15
cigarettes per day among our study participants.
Statistical analyses
Categorical variables are expressed as numbers and percentages
and continuous variables as means with standard deviations (SD).
The hip fracture incidence rate per 10,000 person-years was
calculated by summarizing the follow-up time (years) for the study
population (person-years), and dividing the numbers of hip
fractures on person-years. Linear representation of the categorical
variables was used to test for trend. General linear regression
models (GLM) with femoral neck BMD (g/cm2) as the dependent
variable and fat mass (%) as independent variable were used for
each category of smoking habits. GLM was used to investigate a
possible interaction between fat mass (%) or BMI and smoking on
BMD. BMD was expressed in terms of g/cm2 to give the direct
strength of the relation between BMD and fat mass or BMI in
Smoking, Body Fat Mass and Bone Health
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each smoking category. To get more comprehensible regression
coefficients, fat mass and BMI were divided by 1000 before the
analyses. To test for nonlinearity in the slopes for the association
between fat mass (%) and BMD for each of the different smoking
categories, we used the Davies segmented test [32]. To graphically
express the dose-response associations between fat mass (%) and
BMD according to smoking categories, we used a generalized
additive logistic regression model (GAM) with a smoothing spline
term with adjustment for sex and age group.
Cox proportional hazards regression models were used to
estimate associations between smoking categories in combination
with fat mass (%) or BMI and subsequent hip fracture in the oldest
subjects. These analyses were conducted with and without
adjustments for physical activity and BMD. To study the dose-
response associations between fat mass (%) and the risk of hip
fracture according to smoking categories, a Cox model using a
spline covariate smoothing with adjustment for sex was used. Two-
tailed p-values ,0.05 were considered statistically significant. The
analyses were performed using SPSS for Windows (IBM SPSS
Statistics 19). The generalized additive models were computed
with the R (http://cran.r-project.org) package ‘‘gam’’ [33] and the
Cox spline smoothed curves were constructed using the R package
‘‘survival’’.
Results
Study population
Characteristics of the female and male participants are shown in
Tables 1 and 2, respectively. In women of both age groups, BMI
(kg/m2), fat mass (%), fat mass (kg), lean mass (kg), and BMD (g/
cm2) were significantly lower in heavy smokers than in moderate-,
former-, and never smokers (Table 1). A similar trend was found
among the oldest men (Table 2). In the youngest men, lean mass
and BMD were significantly lower in heavy smokers compared
with the other smoking categories. Among the youngest women
and men, heavy smokers were less physically active than
moderate-, former-, and never smokers. No significant differences
between the smoking groups were found for total energy intake
and use of estrogen supplementation in elderly women. During
follow-up, 100 women and 52 men in the oldest age group suffered
a hip fracture. The hip fracture incidence rates per 10,000 person-
years were 83.5 for women and 54.2 for men. Among the oldest
women, a higher proportion of heavy smokers suffered a hip
fracture compared to moderate and never smokers.
Smoking, fat mass and bone mineral density
For all participants, BMD and fat mass were positively
associated in all smoking categories, with the strongest association
among moderate and heavy smokers (Table 3). Significant
differences in the association (regression coefficients) between fat
mass and BMD between the different smoking categories were
found. Both heavy and moderate smokers had significantly
stronger associations between fat mass and BMD compared to
never smokers (p = 0.018 and p=0.024, respectively) after
adjustment for sex and age group (Table 3). The explained
variance was 0.287 (28.7%) and an overall test of the model gave a
significant fit (F(9,5073) = 226.5, p,0.001). After additional
adjustment for physical activity, the association was significant
among heavy smokers only (p = 0.034) (Table 3). The same
tendency was observed after stratifying on sex and age groups,
although the results were borderline significant (e.g. the oldest
heavy smoking women: differences in regression coefficient = 4.64
per % change in fat mass, 95% confidence interval (CI): 20.07,
9.29; p = 0.050).
Davies segmented test showed that for heavy and moderate
smokers there was a nonlinear association, with a steeper positive
association between BMD and fat mass at low compared to high
values of fat mass, and a significant breakpoint at fat mass of
18.4% in heavy smokers, and at 21.1% in moderate smokers
(p,0.001).
The non-linear dose-response associations (functional form)
between BMD and fat mass are shown in figure 1. The curves
show that BMD increased with increasing levels of fat mass, with
the steepest increases among heavy and moderate smokers with
low fat mass.
The associations were somewhat stronger for BMI as compared
to fat mass (Table S1, Table 3).
Smoking, fat mass and hip fracture
For elderly women and men combined, heavy smokers had an
increased risk of hip fracture compared to never smokers (hazard
ratio = 3.31, 95% CI: 2.05, 5.35; p,0.001) after adjustment for
sex and fat mass. Fat mass was not significantly related to risk of
hip fracture in any of the smoking categories after adjustment for
sex. However, there was a tendency towards heavy smokers having
the strongest fracture risk reduction with increasing fat mass
(Table 4). There were no significant differences between the
associations for the different smoking categories (Table 4).
Adjustment for physical activity and BMD did not materially
change the results (Table 4). Similar results were found when BMI
was used in the analyses instead of fat mass (Table S2).
The association (functional form) between fat mass and the risk
of hip fracture is shown in figure 2, and reveals a non-linear dose-
response relation. There was a tendency towards decreasing risk of
hip fracture with increasing levels of fat mass for each of the
smoking categories, with the steepest decrease among heavy
smokers with low fat mass.
Discussion
In this study the positive association between fat mass and BMD
was stronger among moderate and heavy smokers compared to
never smokers, and the relation was stronger in smokers with low
compared to high fat mass or BMI. In elderly women and men, an
increased risk of hip fracture was associated with heavy smoking.
Fat mass was not significantly related to risk of hip fracture in any
of the smoking categories, but the tendency was that heavy
smokers had higher risk of fractures at lower levels of fat mass, and
that this risk decreased markedly with increasing fat mass.
Strengths of this study are the large number of participants of
both genders, the population based cohort design, and the long
follow-up time of more than 10 years for hip fractures. However,
smoking status, BMD and fat mass were measured only at
baseline; we therefore have no information on potential changes in
these or in other factors during follow-up. All BMD and body
composition measurements were performed on the same DXA
machine. We measured cotinine, which have been reported to
correlate better than self-reports with various effects of smoking
[34]. A total number of 185 participants who reported no current
smoking had plasma cotinine levels above 85 nmol/L. Misclassi-
fication might be related to under-reporting and/or passive
smoking. Data on smokeless tobacco use was not collected, thus
some of the participants with high cotinine levels might have been
snuffers and not cigarette smokers. On the other hand, during
1998–2000, snuffing was very rare among adults and elderly in
Norway, and we do not consider this to be of importance in the
interpretation of our findings. In support of the latter, our results
did not materially change when we used self-reported current
Smoking, Body Fat Mass and Bone Health
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smoking status instead of plasma cotinine in the analyses. Alcohol
abuse is a potential confounding factor, but here were no major
differences in reported alcohol intake within the different smoking
categories, and adjustment for alcohol intake did not alter the
results (data not shown). In addition, diabetes could also be a
confounding factor since persons with diabetes usually have higher
fat mass [35]. However, 166 HUSK participants reported diabetes
and/or use of anti-diabetic medication, and 100 of these had fat
mass above 30% (51 above 40%). Exclusion of these participants
or including diabetes as a covariate did not alter the results.
Percent fat mass was positively related to BMD in all smoking
categories in our study. In the meta-analysis by Ho-Pam et al [23],
studies in which negative correlations between fat mass and BMD
were found included few subjects (n,100) and the negative
correlation coefficients reported were overall weaker than the
(positive) correlations found in other studies. The significant
association between fat mass and BMD may reflect a role of
nutrition and sex hormones in bone building and bone tissue
maintenance [23]. We found a stronger relation between fat mass
and BMD in smokers than non-smokers and in smokers with low
compared to high fat mass. This suggests that among smokers, the
relative impact of fat tissue as an endocrine organ may be more
important among those with little fat mass.
It has been suggested that lower BMD in smokers may be
attributable to lower body weight rather than to a direct effect of
smoking [36]. However, our results do not support that lower BMI
is the predominant explanation as both moderate and heavy
smokers with low fat mass had lower BMD compared to never
Table 1. Characteristics of the female study participants by baseline age group and smoking categories.
Women 46–49 years old Women 71–74 years old
All
Smoking
categoriesb P for All
Smoking
categoriesb P for
subjectsc Never Former Moderate Heavy trendd subjectsc Never Former Moderate Heavy trendd
Number of participants 1821 728 423 341 329 1126 677 275 108 66
(100) (40.0) (23.2) (18.7) (18.1) (100) (60.1) (24.4) (9.6) (5.9)
Body mass index (kg/m2) 24.8 25.2 25.1 24.9 23.6 ,0.001 26.2 26.3 27.1 25.0 23.0 ,0.001
(4.0) (4.3) (3.9) (3.9) (3.5) (4.2) (3.9) (4.6) (4.3) (3.4)
Total fat mass (kg) 24.5 25.4 25.1 24.7 21.5 ,0.001 27.0 27.3 29.1 24.0 20.2 ,0.001
(9.7) (10.1) (9.7) (9.8) (8.2) (9.6) (9.1) (10.4) (9.3) (8.0)
Total lean mass (kg) 40.3 40.5 40.5 40.5 39.6 0.006 37.6 37.8 38.0 37.0 35.1 ,0.001
(4.5) (4.6) (4.2) (4.9) (4.4) (4.3) (4.0) (4.4) (4.7) (4.5)
Fat mass (%) 36.6 37.3 37.1 36.8 34.2 ,0.001 40.6 40.9 42.2 38.0 35.3 ,0.001
(7.8) (7.8) (7.6) (7.6) (7.8) (8.2) (7.7) (8.1) (9.1) (8.7)
Fat mass ,15% 6 1 0 0 5 8 2 1 3 2
(0.3) (0.1) (1.5) (0.7) (0.3) (0.4) (2.8) (3.0)
Fat mass .40% 577 263 138 108 68 ,0.001 635 396 173 46 20 ,0.001
(31.7) (36.1) (32.6) (31.7) (20.7) (56.4) (58.5) (62.9) (42.6) (30.3)
Total energy (kJ/day) 7947.0 7827.8 8042.5 8140.2 7879.3 0.381 6575.9 6561.3 6573.4 6625.2 6666.5 0.701
(2340.0) (2193.7) (2191.4) (2642.8) (2489.6) (2221.1) (2183.5) (2188.9) (2427.0) (2470.3)
No regular physical
activity
655 241 140 116 158 ,0.001 443 273 94 51 25 0.987
(36.4) (33.6) (33.3) (34.6) (48.2) (43.1) (44.5) (36.4) (51.5) (43.1)
Estrogen
supplementation
342 96 99 77 70 ,0.001 125 72 29 15 9 0.406
(25.1) (17.9) (30.6) (30.9) (27.5) (14.9) (14.6) (13.6) (17.6) (18.8)
Femoral neck BMD
(g/cm2)
0.96 0.98 0.96 0.95 0.93 ,0.001 0.76 0.77 0.77 0.74 0.73 0.002
(0.12) (0.13) (0.12) (0.12) (0.13) (0.11) (0.11) (0.12) (0.12) (0.13)
Hip fracture during
follow-upe
4 1 2 - 1 0.858 100 51 22 9 18 ,0.001
(0.2) (0.1) (0.5) (0.3) (8.9) (7.5) (8.0) (8.3) (27.3)
The Hordaland Health Studya.
Abbreviations: BMD, bone mineral density; BMI, body mass index.
aValues are given as mean (standard deviation (SD)) for continuous variables and number (%) for categorical variables.
bNever smoking, plasma cotinine levels,85 nmol/L and no self-reported previous smoking; former smoking, self-reported previous smoking and plasma cotinine levels
,85 nmol/L; moderate smoking, plasma cotinine levels between 85 and 1199 nmol/L; heavy smoking, plasma cotinine levels $1200 nmol/L.
cNumber of participants with data on femoral neck BMD, body soft tissue composition and plasma cotinine.
dP-value for trend across smoking categories.
eHip fractures from inclusion in 1997–99 until December 31st, 2009.
Total numbers may vary between variables due to varying numbers of missing data.
doi:10.1371/journal.pone.0092882.t001
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smokers with low fat mass. This is in accordance with a meta-
analysis demonstrating a negative effect of smoking on BMD
independent of differences in weight between smokers and non-
smokers [2]. On the other hand, we found that smokers with low
fat mass had significantly lower BMD than smokers with high fat
mass. Thus, the negative effect of smoking on BMD seems to be
especially deleterious among lean people.
To our knowledge, there are no published studies using cotinine
to investigate the interaction with fat mass on BMD and
subsequent hip fracture. However, urinary cotinine was
investigated in relation to BMD in a study of pre- and
postmenopausal Korean females, and a significant dose-related
effect of smoking on BMD was observed [37]. In addition, serum
cotinine in relation to bone mineral content (BMC) was
investigated in a large cohort study in the USA and high serum
cotinine levels were found to be a significant risk factor for low
BMC in both women and men [38]. However, the interaction
between smoking and fat mass was not examined in these studies.
We found lower BMD in both moderate and heavy smokers with
low fat mass compared to never smokers with low fat mass. Our
Table 2. Characteristics of the male study participants by baseline age group and smoking categories.
Men 46–49 years old Men 71–74 years old
All Smoking categoriesb P for All Smoking categoriesb P for
subjectsc Never Former Moderate Heavy trendd subjectsc Never Former Moderate Heavy trendd
Number of
participants
1182 404 349 188 241 965 245 555 87 78
(100) (34.2) (29.5) (15.9) (20.4) (100) (25.4) (57.5) (9.0) (8.1)
Body mass
index (kg/m2)
26.2 25.9 26.8 26.4 25.6 0.379 26.0 25.8 26.3 25.7 24.3 0.002
(3.3) (3.2) (3.4) (3.3) (3.3) (3.1) (3.0) (3.0) (3.5) (3.3)
Total fat
mass (kg)
20.6 19.6 22.5 20.8 19.4 0.690 21.2 19.9 22.4 20.4 17.8 0.202
(9.0) (8.4) (9.7) (8.4) (8.9) (8.5) (7.9) (8.5) (8.6) (7.9)
Total lean
mass (kg)
59.9 60.0 60.9 60.2 58.4 0.003 55.0 55.4 55.3 53.9 53.6 0.005
(6.2) (6.1) (6.2) (6.2) (6.0) (5.8) (5.7) (5.8) (5.5) (6.0)
Fat mass (%) 24.7 23.9 26.1 24.9 23.9 0.981 27.0 25.7 28.1 26.6 23.9 0.315
(7.4) (7.2) (7.3) (7.1) (7.8) (7.4) (7.3) (7.2) (7.1) (7.7)
Fat mass
,15%
107 43 19 14 31 55 19 20 5 11
(9.1) (10.6) (5.4) (7.4) (12.9) (5.7) (7.8) (3.6) (5.7) (14.1)
Fat mass
.40%
31 9 14 3 5 0.360 34 7 24 3 0 0.119
(2.6) (2.2) (4.0) (1.6) (2.1) (3.5) (2.9) (4.3) (3.4)
Total energy
(kJ/day)
10547.4 10415.7 10509.4 10409.1 10953.5 0.073 8605.6 8775.5 8510.1 8531.2 8858.3 0.878
(2870.6) (2632.0) (2799.1) (2985.2) (3252.8) (2471.1) (2467.6) (2502.8) (2528.9) (2157.0)
No regular
physical
activity
445 131 126 75 113 ,0.001 273 58 156 40 19 0.059
(38.0) (32.7) (36.3) (40.3) (47.7) (29.3) (24.3) (29.2) (47.6) (25.3)
Femoral
neck BMD
(g/cm2)
0.99 1.00 1.00 0.97 0.95 ,0.001 0.90 0.93 0.90 0.86 0.86 ,0.001
(0.13) (0.13) (0.14) (0.13) (0.12) (0.14) (0.15) (0.14) (0.12) (0.14)
Hip fracture
during
follow-upe
4 2 2 - - 0.231 52 10 29 6 7 0.079
(0.3) (0.5) (0.6) (5.4) (4.1) (5.2) (6.9) (9.0)
The Hordaland Health Studya
Abbreviations: BMD, bone mineral density; BMI, body mass index.
aValues are given as mean (standard deviation (SD)) for continuous variables and number (%) for categorical variables.
bNever smoking, plasma cotinine levels,85 nmol/L and no self-reported previous smoking; former smoking, self-reported previous smoking and plasma cotinine levels
,85 nmol/L; moderate smoking, plasma cotinine levels between 85 and 1199 nmol/L; heavy smoking, plasma cotinine levels $1200 nmol/L.
cNumber of participants with data on femoral neck BMD, body soft tissue composition and plasma cotinine.
dP-value for trend across smoking categories.
eHip fractures from inclusion in 1997–99 until December 31st, 2009.
Total numbers may vary between variables due to varying numbers of missing data.
doi:10.1371/journal.pone.0092882.t002
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results are similar with findings from a Danish study on 2015
perimenopausal women where a significant interaction was found
between self-reported current smoking and fat mass in the lowest
tertile (,13.3 kg) on femoral neck BMD, but not among those in
the highest tertile of fat mass (.19.0 kg) [25]. Two studies
demonstrated a higher risk of low BMD in current smokers
compared with non-smokers in both genders, after adjustment for
BMI [1,39]. In addition, a dose-dependent effect of cigarette
smoking (cigarettes/day, years smoked) on BMD has been
demonstrated in both genders; larger exposure was associated
with lower BMD [2,40].
We observed an increased risk of hip fracture in elderly heavy
smokers compared to never smokers. The association did not
change materially after adjustment for physical activity and BMD,
Table 3. Linear associations between fat mass (%) and femoral neck BMD (g/cm2) for each category of smoking for all participants
(n = 5094) in the Hordaland Health Study.
Adjusted for sex and age Adjusted for sex, age and physical activity
Regression coefficients
Differences in regression
coefficients Regression coefficients
Differences in regression
coefficients
Smoking
categoriesa
B 95% CI P value B 95% CI P value B 95% CI P value B 95% CI P value
Heavy 3.43 2.40, 4.47 ,0.001 1.38 0.24, 2.52 0.018 3.60 2.54, 4.65 ,0.001 1.26 0.10, 2.41 0.034
Moderate 3.35 2.33, 4.36 ,0.001 1.29 0.17, 2.41 0.024 3.32 2.28, 4.36 ,0.001 0.98 20.17, 2.12 0.093
Former 1.30 0.59, 2.01 ,0.001 -0.75 21.60, 0.10 0.082 1.58 0.86, 2.31 ,0.001 20.76 21.62, 0.10 0.084
Never 2.05 1.44, 2.67 ,0.001 0 (ref.) (-,-) - 2.34 1.71, 2.98 ,0.001 0 (ref.) (-,-) -
General linear regression models showing the regression coefficient between fat mass and BMD for each smoking category, and the differences in regression
coefficients per % change in fat mass for each category, with never smokers as the reference group.
Abbreviations: BMD, bone mineral density (g/cm2); B, Beta; CI, confidence interval.
aNever smoking, plasma cotinine levels less than 85 nmol/L and no self-reported previous smoking; former smoking, self-reported previous smoking and plasma
cotinine level .85 nmol/L; moderate smoking, plasma cotinine levels between 85 and 1199 nmol/L; heavy smoking, plasma cotinine levels $1200 nmol/L.
doi:10.1371/journal.pone.0092882.t003
Figure 1. Dose-response curves between fat mass (%) and femoral neck bone mineral density (BMD, g/cm2) for different smoking
categories by generalized additive model (GAM). All participants (n = 5094) are included in the models, which are adjusted for sex and age
group (The Hordaland Health Study). Never smoking is defined as plasma cotinine levels ,85 nmol/L and no self-reported previous smoking; former
smoking, self-reported previous smoking and plasma cotinine levels ,85 nmol/L; moderate smoking, plasma cotinine levels between 85 and
1199 nmol/L; heavy smoking, plasma cotinine levels $1200 nmol/L.
doi:10.1371/journal.pone.0092882.g001
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which suggests that increased fracture risk among heavy smokers
may be independent of BMD. However, we did not find any
significant interaction between fat mass or BMI and the different
smoking categories on the risk of hip fracture which may be due to
the relative small number of hip fractures. In a large Norwegian
study a relative risk of 1.5 (95% CI: 1.0, 2.4) for suffering a hip
fracture was found in female self-reported smokers with BMI
below the population mean (25 kg/m2), compared to lean
non-smokers, increasing to a 3-fold RR when cut-off for BMI
was set at 20 kg/m2 [3]. On the other hand, a population-based
case-control study from Sweden showed an increased risk of hip
fracture in female smokers compared to never smokers (odds
ratio = 1.66, 95% CI: 1.41, 1.95), but with similar results after
dividing the group according to BMI above and below the median
[41]. Hemenway et al [42], did not find any significant association
between cigarettes smoked per day and risk of hip fracture among
Table 4. Associations between fat mass (%) and risk of hip fracture according to smoking status in elderly women and men
(n = 2091) in the Hordaland Health Study.
Adjusted for sex Adjusted for sex, physical activity and BMD
HR for hip fracture by fat mass Differences in HR HR for hip fracture by fat mass Differences in HR
Smoking
categoriesa
HR 95% CI P value HR 95% CI P value HR 95% CI P value HR 95% CI P value
Heavy 0.67 0.42, 1.07 0.091 0.78 0.44, 1.37 0.391 0.80 0.62, 1.03 0.082 0.87 0.61, 1,24 0.424
Moderate 0.79 0.47, 1.32 0.368 0.92 0.50, 1.69 0.791 0.87 0,69, 1.11 0.259 0.95 0.68, 1.31 0.738
Former 1.05 0.73, 1.50 0.798 1.23 0.77, 1.96 0.394 0.92 0.65, 1.30 0.643 0.95 0.62, 1.45 0.811
Never 0.85 0.62, 1.19 0.348 1.00 (-,-) - 0.88 0.62, 1,24 0.452 1.00 (-,-) -
Cox proportional hazards regression models showing hazard ratio between fat mass and hip fracture within each smoking category, and differences in HRs between
each smoking category compared to never smokers.
Abbreviations: HR, hazard ratio; CI, confidence interval.
aNever smoking, plasma cotinine levels ,85 nmol/L and no self-reported previous smoking; former smoking, previous self-reported smoking and plasma cotinine levels
,85 nmol/L; moderate smoking, plasma cotinine levels between 85 and 1199 nmol/L; heavy smoking, plasma cotinine levels $1200 nmol/L.
doi:10.1371/journal.pone.0092882.t004
Figure 2. Dose-response curves between fat mass (%) and risk of hip fracture according to smoking status in elderly women and
men (n = 2091) by generalized additive Cox modeling. The curves are adjusted for sex (The Hordaland Health Study). Never smoking is defined
as plasma cotinine levels ,85 nmol/L and no self-reported previous smoking; former smoking, previous self-reported smoking and plasma cotinine
levels ,85 nmol/L; moderate smoking, plasma cotinine levels between 85 and 1199 nmol/L; heavy smoking, plasma cotinine levels $1200 nmol/L.
doi:10.1371/journal.pone.0092882.g002
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women, nor any interaction with body weight. Forsen et al [3],
found an increased risk of hip fractures in male smokers
independently of BMI. In some other studies on male smokers
the results are conflicting regarding impact of BMI or weight on
risk of fracture [43,44].
We did not find any significant differences in the association
between fat mass and the risk of low BMD or hip fracture in
former smokers compared to never smokers. In some previous
studies with adjustment for BMI, smoking cessation was found to
both decrease the risk of low BMD [2,40] and hip fracture [44] as
well as to increase the risk of hip fracture [45]. The number of
years smoked and time since quitting may be important [2]. In the
study by Hollenback et al [40], previous smokers with short time
since smoking cessation had lower hip BMD than never smokers
and long-term quitters, while current smokers had the lowest
BMD. In a large Norwegian study of women and men under 75
years, the risk of hip fracture was higher in former smokers, even
among those who had quit smoking more than 5 years before,
compared to never smokers [45].
The mechanisms behind the negative effects of smoking on
bone are not completely known. In women, positive associations
between tobacco smoking, premature menopause [25], low
estrogen levels [5] and low BMD have been found. In addition,
a more rapid bone loss after menopause in smokers than non-
smokers has been observed [46]. It has been estimated that
smoking increases the lifetime risk of sustaining a hip fracture by
31% in women and 40% in men [2], and bone loss has been
reported to be more rapid among male than female smokers [47].
The apparently higher risk among men may be due to a higher
total consumption of cigarettes among male smokers, or a
protective effect of hormone replacement therapy among women
[2]. However, in the current study the prevalence of hip fracture
was higher among female than male smokers. Smoking has also
been shown to reduce testosterone levels in men [48]. A adverse
effect of smoking on skeletal remodeling and bone cells has been
observed [6]. Further, smoking may affect other hormones,
minerals and enzymes involved in bone regulation resulting in
reduced calcium absorption [8] and parathyroid hormone
concentration [9]. Increased oxidative stress and inflammation
are also observed in smokers [49].
Generally, and as we observed, smokers have lower BMI and
lower fat mass than non-smokers [25]. It has been suggested that
smoking has an appetite-suppressing effect, thereby leading to
lower energy intake. However, we and others [50] did not find any
significant differences in the total energy intake between smokers
and non-smokers. A modestly increased rate of energy metabolism
in smokers compared to non-smokers due to release of hormones
as e.g. adrenaline from the central nervous system has been
suggested [51].
The biochemical pathways linking adipose tissue to bone are
complex [24]. For example, in women a decreased rate of bone
loss might be explained by the production of extragonadal
estrogen in adipose tissue after menopause. Thus, postmenopausal
women with low fat mass have lower estrogen production and
therefore a higher risk of osteoporosis [24]. In elderly men,
androgen deficiency caused by hypogonadism may contribute to
bone loss, but androgen deficiency is not related to fat mass [52].
However, low estradiol levels in elderly men may also cause faster
bone loss [16].
Our findings indicate that the positive relation between fat mass
and BMD was stronger among moderate and heavy smokers
compared to never smokers, and the deleterious effect was stronger
in smokers with low compared to high fat mass. Thus, physicians
should be particularly attentive to lean smokers concerning the risk
of osteoporosis. An uplifting finding in our study as well as in other
studies [2] is that it seems that smoking cessation may slow down
or partially reverse the accelerated bone loss caused by years of
smoking. There is no convincing evidence that fat mass per se
protects against osteoporosis or hip fractures. For a deeper
understanding, further research should aim at investigating
through which pathways fat tissue may exert a protective effect
on bone exposed to toxic substances.
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